Bundling mRNA Strands to Prepare Nano‐Assemblies with Enhanced Stability Towards RNase for In Vivo Delivery
Year: 2019
Type: article
Abstract: Ribonuclease (RNase)-mediated degradation of messenger RNA (mRNA) poses a huge obstruction to in vivo mRNA delivery. Herein, we propose a novel strategy to protect mRNA by structuring mRNA to prevent RNase attack through steric hinderance. Bundling of mRNA strands through hybridization of RNA oligonucleotide linkers allowed the preparation of mRNA nano-assemblies (R-NAs) comprised of 7.7 mRNA strands on average, mostly below 100 nm in diameter. R-NA formation boosted RNase stability by around 100-fold compared to naïve mRNA and preserved translational activity, allowing protein production. A mechanistic analysis suggests that an endogenous mRNA unwinding mechanism triggered by 5'-cap-dependent translation may induce selective R-NA dissociation intracellularly, leading to smooth translation. R-NAs showed efficient mRNA transfection in mouse brain, demonstrating the feasibility for in vivo administration.
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Awards: Development of a nano-pharmaceutical strategy for safely and effectively treating pregnant cancer patients, G1751687152, G1839534493, G3130158853, Development and scientific creation of structured gene carriers based on controlled higher-order structures of pDNA, Development of mRNA drug with RNA type aptamer conferring cell type specific translation activation function, Minimized packaging of pDNA within polyplex micelles and systemic gene therapy for pancreatic cancer., G5702055614, Development of immunostimulatory mRNA and lymphoid tissue-targeting carriers for cancer vaccine, Determination of therapeutic factors using extracellular vesicles secreted from 3D-cultured stem cells, Fabrication of drug delivery systems targeting muscle tissues, G8343586607
OpenAlex ID: W2950809830
